Search results
436 Results for 'Bioinspired Therapeutics'
- Technologies (31)
- Collaborations (7)
- Team (0)
- News (304)
- Pages (0)
- Multimedia (94)
- Publications (0)
- Jobs (0)
- Events (0)
Technologies 31
-
MenoSense: A Scalable At-Home Platform for Precision Women’s Health
We’re developing an at-home platform combining repeated hormone measurements with symptom tracking to help women understand their menopause transition. By revealing patterns over time, it could inform clinician conversations, advance menopause research, and support more personalized treatment selection, monitoring, and management. -
Blood Clot Dx
An ultra-sensitive triage test that identifies patients at risk for blood clots before they happen, enabling proactive treatment to reduce complications and deaths across a wide range of conditions. -
Ropirio: Novel Treatments Targeting the Lymphatic System
Ropirio is commercializing the world’s first drug that directly targets and reactivates lymph vessels, a portfolio of other lymph-targeting small molecules, and a preclinical platform for discovering more. -
Instrument-Free Molecular Diagnostics
A synthetic biology-based molecular diagnostics platform that enables the creation of low-cost, highly accurate tests for non-clinical settings. -
Ichor: Reversing Aging
Ichor is addressing multiple age-related diseases by identifying genetic interventions that reprogram old cells to a younger state. Therapies based on these interventions could improve survival for cancer patients and long-term cardiovascular and neurological health. -
NodeTX: Growing Lymph Nodes to Treat Cancer
NodeTX is a novel immunotherapy that leverages the human body's innate ability to grow lymph nodes to fight tumors.
Collaborations 7
-
Nucleic Acid Delivery Consortium
An academic-industry consortium focused on the challenge of delivering nucleic acid-based therapies to specific target organs, tissues, and cells. -
Brain Targeted Therapeutic Collaboration
Combine our shuttles with your drugs to create new brain targeted therapeutics for patients. -
Brain Shuttle Research Sponsorship & Licensing
Enabling brain-targeted drug development through non-exclusive licensing and pre-competitive research sponsorship. -
Bridging the Funding Gap for Brain Therapeutics
A unique opportunity to help develop a new generation of brain targeted drugs -
Biomarker Discovery Laboratory (BDL)
Bridging the diagnostic gap from biomarker discovery to market-ready test kits and instruments through cutting-edge technology development and clinical collaboration. -
Kraft Heinz Partnership
The Kraft Heinz company approached the Wyss Institute for help to achieve its ambitious goal to make its food products healthier, resulting in a novel technology that is ripe for commercialization.
News 304
Multimedia 94
-
Video/AnimationInside the Wyss Institute at Harvard | Materials Saving the FutureFrom developing plastics that actually break down to adhesive gels for surgery, the Wyss Institute’s materials scientists are working to save the future. Four Wyss researchers, Principal Scientist in Sustainable Materials Emily Stoler, Ph.D., Senior Scientist Peter Nguyen, Ph.D., Wyss Lumineer Benjamin Freedman, Ph.D., and Postdoctoral Fellow Namrata Ramani, Ph.D., speak with host Ashley Christine... -
Video/AnimationCutting to the Case: Don IngberDon Ingber, M.D., Ph.D., is the Founding Director of Harvard University’s Wyss Institute for Biologically Inspired Engineering and a pioneer of organ-on-a-chip technology. In this episode of Cutting to the Case, Ingber and host Cameron Sabet discuss how he helped create organs-on-chips, what these systems can teach us that traditional models cannot, and how biologically... -
Audio/PodcastBuying time: A medical breakthrough in stroke treatmentWhen a stroke strikes, every minute matters. Science has traditionally approached stroke as a race against time. But rather than racing faster, what if we could instead slow the damage down? Join host Shahni Wellington as she explores groundbreaking research aimed at buying more time for stroke patients, particularly those in rural and regional communities.... -
Audio/PodcastNext-Gen Toxicology: Inside the Organ Chip Revolution with Donald IngberIn this episode of ToxChats, hosts Lauren Walker and Sarah Benjamin sit down with the groundbreaking Donald Ingber—visionary scientist, engineer, and Founding Director of the Wyss Institute. Ingber shares how his unique path through medicine, biology, and design converged to spark breakthroughs such as human Organ Chips—systems that are redefining toxicology, drug development, and disease...
-
Video/Animation20-ish Questions with Donald E. Ingber20-ish Questions shows a different side of Wyss Institute faculty, touching on aspects of their personal life, hobbies, interests, as well as their research. This round follows Donald E. Ingber, the Founding Director and a Core Faculty member at the Wyss Institute. He is also the Judah Folkman Professor of Vascular Biology at Harvard Medical... -
Video/AnimationAVATARs for Astronaut Health Are Heading to Space!NASA’s AVATAR experiment is flying aboard Artemis II to study how deep space affects human health. Using Organ Chips containing astronaut cells, Emulate and Wyss Institute researchers will examine how radiation and microgravity impact human tissue. This research will help inform medical strategies for future long-duration missions to Mars and beyond. The findings could also...